# A Randomized Clinical Evaluation of the BioFreedom™ Stent

Study · id `cardio:ct-nct01623180` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01623180](<https://clinicaltrials.gov/study/NCT01623180>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01623180

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 2456 participants.

## Technical summary

Registry record NCT01623180. Randomized; quadruple masking; primary purpose treatment. Start 2012-12 (registry gives no type); primary completion 2015-05 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 2456 participants (planned count; ClinicalTrials.gov record NCT01623180, source copy `cardio:ctgov-nct01623180-2015-08-19`, retrieved 2026-10-26)
- Start date: 2012-12 (registry gives no type) (ClinicalTrials.gov record NCT01623180, source copy `cardio:ctgov-nct01623180-2015-08-19`, retrieved 2026-10-26)
- Primary completion: 2015-05 (actual) (ClinicalTrials.gov record NCT01623180, source copy `cardio:ctgov-nct01623180-2015-08-19`, retrieved 2026-10-26)
- Completion: 2016-06 (anticipated) (ClinicalTrials.gov record NCT01623180, source copy `cardio:ctgov-nct01623180-2015-08-19`, retrieved 2026-10-26)
- Countries: Switzerland (ClinicalTrials.gov record NCT01623180, source copy `cardio:ctgov-nct01623180-2015-08-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01623180-2015-08-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Randomized Clinical Evaluation of the BioFreedom™ Stent
- Acronym: Leaders Free
- Condition: Stable Angina
- Condition: Ischemic Heart Disease Silent
- Condition: ST Elevation (STEMI) and Non-ST Elevation (NSTEMI) Myocardial Infarction
- Condition: In-stent Coronary Artery Restenosis
- Condition: Bleeding
- Intervention (Device): Biofreedom™ Drug Coated Stent (DCS)
- Intervention (Device): Gazelle™ Bare Metal Coronary Stent (BMS)
- Lead sponsor: Biosensors Europe SA
- Lead sponsor class: INDUSTRY
- Collaborator: European Cardiovascular Research Center
- Collaborator class: NETWORK

## Connected pages

- Registry condition terms include this condition: Angina pectoris (`cardio:angina-pectoris`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: Non-ST-elevation heart attack (NSTEMI) (`cardio:nstemi`)
- Registry condition terms include this condition: Stable angina (`cardio:stable-angina`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry lists this organization as the lead sponsor: Biosensors Europe SA (`cardio:org-biosensors-europe-sa`)
- Registry lists this organization as a collaborator: European Cardiovascular Research Center (`cardio:org-european-cardiovascular-research-center`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk (`cardio:pubmed-26466021`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: 2-Year Outcomes of High Bleeding Risk Patients After Polymer-Free Drug-Coated Stents (`cardio:pubmed-27806919`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Safety and Efficacy of Polymer-Free Biolimus A9-Coated Versus Bare-Metal Stents in Orally Anticoagulated Patients: 2-Year Results of the LEADERS FREE Oral Anticoagulation Substudy (`cardio:pubmed-28838473`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Polymer-free drug-coated coronary stents in diabetic patients at high bleeding risk: a pre-specified sub-study of the LEADERS FREE trial (`cardio:pubmed-29951803`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 28ebbedf15f7ff2204b3ced80fb4d82a2000a52f126760c1e58fc97a3c18b54f
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
